Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology

被引:149
作者
Kiuru, M
Launonen, V
Hietala, M
Aittomäki, K
Vierimaa, O
Salovaara, R
Arola, J
Pukkala, E
Sistonen, P
Herva, R
Aaltonen, LA
机构
[1] Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland
[3] Turku Univ Hosp, Dept Clin Genet, FIN-20520 Turku, Finland
[4] Turku Univ Hosp, Dept Med Genet, FIN-20520 Turku, Finland
[5] Oulu Univ Hosp, Dept Clin Genet, Oulu, Finland
[6] Oulu Univ Hosp, Dept Pathol, Oulu, Finland
[7] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland
[8] Finnish Red Cross & Blood Transfus Serv, SF-00310 Helsinki, Finland
基金
芬兰科学院;
关键词
D O I
10.1016/S0002-9440(10)61757-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Little has been known about the molecular background of familial multiple cutaneous leiomyomatosis (MCL). We report here a clinical, histopathological, and molecular study of a multiple cutaneous leiomyomatosis kindred with seven affected members. This detailed study revealed strong features of a recently described cancer predisposition syndrome, hereditary leiomyomatosis and renal cell cancer (HLRCC). The family was compatible with linkage to the HLRCC locus in 1q. Also, all seven cutaneous leiomyomas derived from the proband and analyzed for loss of heterozygosity displayed loss of the wildtype allele, confirming the association with a susceptibility gene in chromosome 1q. One individual had had renal cell cancer at the age of 35 years. This tumor displayed a rare papillary histopathology, which appears to be characteristic for HLRCC. The derived linkage, loss of heterozygosity, and clinical data suggest that MCL and HLRCC are a single disease with a variable phenotype. The possibility that members of leiomyomatosis families are predisposed to renal cell cancer should be taken into account.
引用
收藏
页码:825 / 829
页数:5
相关论文
共 24 条
[1]   Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43 [J].
Alam, NA ;
Bevan, S ;
Churchman, M ;
Barclay, E ;
Barker, K ;
Jaeger, EEM ;
Nelson, HM ;
Healy, E ;
Pembroke, AC ;
Friedmann, PS ;
Dalziel, K ;
Calonje, E ;
Anderson, J ;
August, PJ ;
Davies, MG ;
Felix, R ;
Munro, CS ;
Murdoch, M ;
Rendall, J ;
Kennedy, S ;
Leigh, IM ;
Kelsell, DP ;
Tomlinson, IPM ;
Houlston, RS .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (05) :1264-1269
[2]  
[Anonymous], 1854, VIRCHOWS ARCH PATHOL
[3]  
COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
[4]   THE FREQUENCY OF UTERINE LEIOMYOMAS [J].
CRAMER, SF ;
PATEL, A .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (04) :435-438
[5]  
ENGELKE H, 1979, ACTA DERM-VENEREOL, V59, P51
[6]   FAMILIAL MULTIPLE CUTANEOUS LEIOMYOMAS [J].
FERNANDEZPUGNAIRE, MA ;
DELGADOFLORENCIO, V .
DERMATOLOGY, 1995, 191 (04) :295-298
[7]   9P TRISOMY 18P DISTAL MONOSOMY AND MULTIPLE CUTANEOUS LEIOMYOMATA - ANOTHER SPECIFIC CHROMOSOMAL SITE (18PTER) IN DOMINANTLY INHERITED MULTIPLE TUMORS [J].
FRYNS, JP ;
HASPESLAGH, M ;
DEMUELENAERE, A ;
VANDENBERGHE, H .
HUMAN GENETICS, 1985, 70 (03) :284-286
[8]   Landscaping the cancer terrain [J].
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 280 (5366) :1036-1037
[9]  
KLOEPFER HW, 1958, AM J HUM GENET, V10, P48